Inventor · disambiguated record
Michael Jarsch
Also filed as: JARSCH MICHAEL
18 granted patents·5 pending applications·76 citations·filing 1988–2020
92Inventor score
Files withBOEHRINGER MANNHEIM GMBH13HOFFMANN LA ROCHE3HASELBECK ANTON2JARSCH MICHAEL2DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS1
Top patents by PatentIndex Score
23 records- 0166US8623666B2Method for detecting erythropoietin (EPO) receptor using anti-human EPO receptor antibodiesJARSCH MICHAEL·Filed 2012·Granted Jan 7, 2014·1 cites·10 claims
- 0258US9187563B2Anti-human EPO receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2013·Granted Nov 17, 2015·0 cites·15 claims
- 0358US5308770ACloning and overexpression of glucose-6-phosphate dehydrogenase from Leuconostoc dextranicusBOEHRINGER MANNHEIM GMBH·Filed 1993·Granted May 3, 1994·14 cites·17 claims
- 0458US5229286ACloning and overexpression of glucose-6-phosphate dehydrogenase from leuconostoc dextranicusBOEHRINGER MANNHEIM GMBH·Filed 1991·Granted Jul 20, 1993·14 cites·1 claims
- 0556US2011165592A1Antibodies against human epo receptorHOFFMANN LA ROCHE·Filed 2009·Application pending·0 cites
- 0654US10796799B2Methods for the prediction of a personalized ESA-dose in the treatment of anemiaDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2015·Granted Oct 6, 2020·1 cites·8 claims
- 0754US2010267632A1Treatment of neurodegenerative disordersHASELBECK ANTON·Filed 2008·Application pending·0 cites
- 0849US5434067AProcess for the production and renaturation of recombinant, biologically active, eukaryotic alkaline phosphataseBOEHRINGER MANNHEIM GMBH·Filed 1993·Granted Jul 18, 1995·12 cites·26 claims
- 0948US5158878AType ii restriction endonuclease swaiBOEHRINGER MANNHEIM GMBH·Filed 1991·Granted Oct 27, 1992·13 cites·10 claims
- 1047US2021093696A1Methods for the prediction of a personalized esa-dose in the treatment of anemiaDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS·Filed 2020·Application pending·0 cites
- 1146US2007072795A1Treatment of neurodegenerative disordersHASELBECK ANTON·Filed 2005·Application pending·0 cites
- 1244US5916759ACholesterol oxidase from Brevibacterium sterolicumBOEHRINGER MANNHEIM GMBH·Filed 1994·Granted Jun 29, 1999·6 cites·12 claims
- 1344US2011143372A1Antibodies against human epo receptorHOFFMANN LA ROCHE·Filed 2011·Application pending·0 cites
- 1440US5830720ARecombinant DNA and expression vector for the repressible and inducible expression of foreign genesBOEHRINGER MANNHEIM GMBH·Filed 1995·Granted Nov 3, 1998·5 cites·31 claims
- 1538US9221909B2Antibodies against human EPO receptorJARSCH MICHAEL·Filed 2010·Granted Dec 29, 2015·0 cites·11 claims
- 1634US5183747AType ii restriction endonuclease ssp4800iBOEHRINGER MANNHEIM GMBH·Filed 1991·Granted Feb 2, 1993·2 cites·10 claims
- 1733US5134069AType ii restriction endonuclease sgraiBOEHRINGER MANNHEIM GMBH·Filed 1990·Granted Jul 28, 1992·3 cites·10 claims
- 1830US5153122AType ii restriction endonuclease mamiBOEHRINGER MANNHEIM GMBH·Filed 1989·Granted Oct 6, 1992·0 cites·13 claims
- 1930US4970149AClass II restriction endonuclease Ksp632I, a process for obtaining it and the use thereofBOEHRINGER MANNHEIM GMBH·Filed 1988·Granted Nov 13, 1990·1 cites·7 claims
- 2029US5134067AType ii restriction endonuclease rleaiBOEHRINGER MANNHEIM GMBH·Filed 1990·Granted Jul 28, 1992·0 cites·10 claims
- 2129US4975376AClass II restriction endonuclease KspI and a process for obtaining itBOEHRINGER MANNHEIM GMBH·Filed 1989·Granted Dec 4, 1990·2 cites·6 claims
- 2228US6190906B1Expression vector for the regulatable expression of foreign genes in prokaryotesROCHE DIAGNOSTICS GMBH·Filed 1989·Granted Feb 20, 2001·2 cites·14 claims
- 2328US5134068AType ii restriction endonucleae mcriBOEHRINGER MANNHEIM GMBH·Filed 1990·Granted Jul 28, 1992·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Michael Jarsch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →